257 related articles for article (PubMed ID: 31435020)
1. Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin.
Yu X; Wang R; Zhang Y; Zhou L; Wang W; Liu H; Li W
Oncogene; 2019 Dec; 38(50):7457-7472. PubMed ID: 31435020
[TBL] [Abstract][Full Text] [Related]
2. Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
Zhou L; Yu X; Li M; Gong G; Liu W; Li T; Zuo H; Li W; Gao F; Liu H
EBioMedicine; 2020 Jan; 51():102570. PubMed ID: 31806563
[TBL] [Abstract][Full Text] [Related]
3. Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance.
Dong X; Liu W; Li X; Gan Y; Zhou L; Li W; Xie L
Sci Rep; 2022 Nov; 12(1):20644. PubMed ID: 36450751
[TBL] [Abstract][Full Text] [Related]
4. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
5. Gastrodin overcomes chemoresistance via inhibiting Skp2-mediated glycolysis.
Xie L; Liao J; Liu W; Wang R; Li X; Li W; Zhou Z
Cell Death Discov; 2023 Oct; 9(1):364. PubMed ID: 37779163
[TBL] [Abstract][Full Text] [Related]
6. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis.
Chan CH; Li CF; Yang WL; Gao Y; Lee SW; Feng Z; Huang HY; Tsai KK; Flores LG; Shao Y; Hazle JD; Yu D; Wei W; Sarbassov D; Hung MC; Nakayama KI; Lin HK
Cell; 2012 May; 149(5):1098-111. PubMed ID: 22632973
[TBL] [Abstract][Full Text] [Related]
7. Skp2 stabilizes Mcl-1 and confers radioresistance in colorectal cancer.
Yu X; Zhou L; Liu W; Liu L; Gao F; Li W; Liu H
Cell Death Dis; 2022 Mar; 13(3):249. PubMed ID: 35301297
[TBL] [Abstract][Full Text] [Related]
8. Skp2-mediated MLKL degradation confers cisplatin-resistant in non-small cell lung cancer cells.
Zhou H; Zhou L; Guan Q; Hou X; Wang C; Liu L; Wang J; Yu X; Li W; Liu H
Commun Biol; 2023 Aug; 6(1):805. PubMed ID: 37532777
[TBL] [Abstract][Full Text] [Related]
9. E3-ligase Skp2 predicts poor prognosis and maintains cancer stem cell pool in nasopharyngeal carcinoma.
Wang J; Huang Y; Guan Z; Zhang JL; Su HK; Zhang W; Yue CF; Yan M; Guan S; Liu QQ
Oncotarget; 2014 Jul; 5(14):5591-601. PubMed ID: 25015320
[TBL] [Abstract][Full Text] [Related]
10. The critical role of AMPK in driving Akt activation under stress, tumorigenesis and drug resistance.
Han F; Li CF; Cai Z; Zhang X; Jin G; Zhang WN; Xu C; Wang CY; Morrow J; Zhang S; Xu D; Wang G; Lin HK
Nat Commun; 2018 Nov; 9(1):4728. PubMed ID: 30413706
[TBL] [Abstract][Full Text] [Related]
11. Asiatic Acid, Extracted from
Liu YT; Chuang YC; Lo YS; Lin CC; Hsi YT; Hsieh MJ; Chen MK
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31991751
[TBL] [Abstract][Full Text] [Related]
12. Curcumol Reduces Aerobic Glycolysis and Overcomes Chemoresistance by Inducing Cdh1-Mediated Skp2 Ubiquitination.
Gan Y; Zhou L; Wang R; Zhang Y; Li X; Han S; Rong P; Wang W; Li W
Am J Chin Med; 2023; 51(3):723-740. PubMed ID: 36866798
[TBL] [Abstract][Full Text] [Related]
13. CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization.
Hong X; Li Q; Li J; Chen K; He Q; Zhao Y; Liang Y; Zhao Y; Qiao H; Liu N; Ma J; Li Y
Clin Cancer Res; 2022 Oct; 28(20):4521-4535. PubMed ID: 35917517
[TBL] [Abstract][Full Text] [Related]
14. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance.
Zheng ZQ; Li ZX; Guan JL; Liu X; Li JY; Chen Y; Lin L; Kou J; Lv JW; Zhang LL; Zhou GQ; Liu RQ; Chen F; He XJ; Li YQ; Li F; Xu SS; Ma J; Liu N; Sun Y
Cancer Res; 2020 Dec; 80(23):5174-5188. PubMed ID: 33067266
[TBL] [Abstract][Full Text] [Related]
16. Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
Li B; Lu W; Yang Q; Yu X; Matusik RJ; Chen Z
Prostate; 2014 Apr; 74(4):421-32. PubMed ID: 24347472
[TBL] [Abstract][Full Text] [Related]
17. Exosomal transfer of miR-106a-5p contributes to cisplatin resistance and tumorigenesis in nasopharyngeal carcinoma.
Li J; Hu C; Chao H; Zhang Y; Li Y; Hou J; Huang L
J Cell Mol Med; 2021 Oct; 25(19):9183-9198. PubMed ID: 34469038
[TBL] [Abstract][Full Text] [Related]
18. SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma.
Shao Y; Ren W; Dai H; Yang F; Li X; Zhang S; Liu J; Yao X; Zhao Q; Sun X; Zheng Z; Xu C
Mol Cells; 2023 Jun; 46(6):360-373. PubMed ID: 36694914
[TBL] [Abstract][Full Text] [Related]
19. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway.
Liu Y; Jiang Q; Liu X; Lin X; Tang Z; Liu C; Zhou J; Zhao M; Li X; Cheng Z; Li L; Xie Y; Liu Z; Fang W
EBioMedicine; 2019 Oct; 48():386-404. PubMed ID: 31594754
[TBL] [Abstract][Full Text] [Related]
20. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
